NovaBridge Biosciences (NBP) Intangibles (2018 - 2023)

NovaBridge Biosciences (NBP) has 6 years of Intangibles data on file, last reported at $16.4 million in Q4 2023.

• Intangibles for Q4 2023 came in at $16.4 million, down 1.87% year-over-year; the trailing twelve-month figure through Dec 2023 was $16.4 million (down 1.87% YoY), and the FY2023 annual result was $16.7 million, down 99.9% from the prior year.
• Intangibles was little changed at $16.4 million in Q4 2023 per NBP's latest filing, from $16.3 million in the prior quarter.
• Over five years, Intangibles peaked at $18.7 billion in Q4 2021 and troughed at $16.3 million in Q2 2023.
• A 5-year average of $1.9 billion and a median of $18.1 million in 2020 frame the typical range for Intangibles.
• The sharpest annual moves came in 2021 and 2022: Intangibles soared 102886.2% in 2021, then tumbled 99.91% in 2022.
• A 5-year view of Intangibles shows it stood at $21.1 million in 2019, then retreated by 13.94% to $18.2 million in 2020, then soared by 102886.2% to $18.7 billion in 2021, then plunged by 99.91% to $16.7 million in 2022, then decreased by 1.87% to $16.4 million in 2023.
• Business Quant data shows NBP's Intangibles at $16.4 million in Q4 2023, $16.3 million in Q2 2023, and $16.7 million in Q4 2022.